维持性血液透析患者血管钙化危险因素研究进展
Research Progress on Risk Factors for Vascular Calcification in Maintenance Hemodialysis Patients
DOI: 10.12677/ACM.2023.1371561, PDF,   
作者: 张家玉, 李六生*：三峡大学人民医院肾内科，湖北 宜昌
关键词: 血管钙化；维持性血液透析；危险因素；Vascular Calcification； Maintenance Hemodialysis； Risk Factors
摘要: 心血管并发症是维持性血液透析患者最主要的死亡原因，血管钙化是心血管并发症的独立危险因子，同时会增加患者的死亡风险。维持性血液透析患者的血管钙化是多因素共同作用的结果，控制危险因素可以有效延缓血管钙化的发生发展，对降低维持性血液透析患者心血管事件的发生率及死亡率，改善预后有重要意义。目前，传统危险因素已不能解释患者血管钙化的高发生率，非传统因素对血管钙化的影响越来越为人们所关注，本文就维持性血液透析患者血管钙化的非传统因素进行综述。
Abstract: Cardiovascular complications are the most important cause of death in maintenance hemodialysis (MHD) patients. Vascular calcification (VC) is an independent risk factor for cardiovascular com-plications, which also increases the risk of death for patients. Vascular calcification in maintenance hemodialysis patients is the result of multiple factors. Controlling risk factors can effectively delay the occurrence and development of vascular calcification, which is of great significance in reducing the incidence and mortality rate of cardiovascular events and improving prognosis in maintenance hemodialysis patients. Currently, traditional risk factors cannot explain the high incidence of vascular calcification in patients. The impact of non-traditional factors on vascular calcification has attracted more and more attention. This article summarizes the non-traditional factors of vascular calcification in patients with maintenance hemodialysis.
文章引用：张家玉, 李六生. 维持性血液透析患者血管钙化危险因素研究进展[J]. 临床医学进展, 2023, 13(7): 11180-11186. https://doi.org/10.12677/ACM.2023.1371561

参考文献

[1] Hill, N.R., Fatoba, S.T., Oke, J.L., et al. (2016) Global Prevalence of Chronic Kidney Disease—A Systematic Review and Meta-Analysis. PLOS ONE, 11, e158765. [Google Scholar] [CrossRef] [PubMed]
[2] Zhang, L., Wang, J., Yang, C.W., et al. (2021) International Society of Nephrology Global Kidney Health Atlas: Structures, Organization and Services for the Management of Kidney Failure in North and East Asia. Kidney International Supplements (2011), 11, e77-e85. [Google Scholar] [CrossRef] [PubMed]
[3] 刘志红. 中华医学会肾脏病学分会慢性肾脏病矿物质和骨异常诊治指导[C]//中华医学会肾脏病学分会2013年学术年会论文集. 2013: 3.
[4] Liu, Z.H., Yu, X.Q., Yang, J.W., et al. (2018) Prevalence and Risk Factors for Vascular Calcification in Chinese Patients Receiving Dialysis: Baseline Results from a Prospective Cohort Study. Current Medical Research and Opinion, 34, 1491-1500. [Google Scholar] [CrossRef] [PubMed]
[5] Zununi, V.S., Mostafavi, S., Hosseiniyan, K.S., et al. (2020) Vascular Calcification: An Important Understanding in Nephrology. Vascular Health and Risk Management, 16, 167-180. [Google Scholar] [CrossRef] 
[6] Carrillo-Lopez, N., Panizo, S., Alonso-Montes, C., et al. (2019) High-Serum Phosphate and Parathyroid Hormone Distinctly Regulate Bone Loss and Vascular Calcification in Experimental Chronic Kidney Disease. Nephrology Dialysis Transplantation, 34, 934-941. [Google Scholar] [CrossRef] [PubMed]
[7] 魏萌, 魏丽敏, 王萌, 等. 维持性血液透析患者血管钙化的危险因素分析[J]. 中国血液净化, 2020, 19(11): 742-746.
[8] Yamada, S., Taniguchi, M., Tokumoto, M., et al. (2012) The Antioxidant Tempol Ameliorates Arterial Medial Calcification in Uremic Rats: Important Role of Oxidative Stress in the Pathogenesis of Vascular Calcification in Chronic Kidney Disease. Journal of Bone and Mineral Research, 27, 474-485. [Google Scholar] [CrossRef] [PubMed]
[9] Muteliefu, G., Enomoto, A., Jiang, P., et al. (2009) Indoxyl Sulphate Induces Oxidative Stress and the Expression of Osteoblast-Specific Proteins in Vascular Smooth Muscle Cells. Nephrology Dialysis Transplantation, 24, 2051-2058. [Google Scholar] [CrossRef] [PubMed]
[10] 马莉莉, 蒋麟, 王婷婷, 等. 高基础水平血尿酸与动脉硬化的相关性及其预测作用[J]. 临床和实验医学杂志, 2020, 19(7): 748-751.
[11] Tani, M., Tanaka, S., Takamiya, K., et al. (2020) Effects of Repetitive Diet-Induced Fluctuations in Plasma Phosphorus on Vascular Calcification and Inflammation in Rats with Early-Stage Chronic Kidney Disease. Journal of Clinical Biochemistry and Nutrition, 66, 139-145. [Google Scholar] [CrossRef] [PubMed]
[12] Jono, S., McKee, M.D., Murry, C.E., et al. (2000) Phosphate Regulation of Vascular Smooth Muscle Cell Calcification. Circulation Research, 87, E10-E17. [Google Scholar] [CrossRef] 
[13] Park, K.S., Park, J., Choi, S.H., et al. (2016) Serum Phosphorus Concentration and Coronary Artery Calcification in Subjects without Renal Dysfunction. PLOS ONE, 11, e151007. [Google Scholar] [CrossRef] [PubMed]
[14] 柳青, 王迪生. 低钙透析液联合高通量血液透析对尿毒症患者钙磷及血管钙化的影响[J]. 临床医药文献电子杂志, 2019, 6(55): 74.
[15] Tentori, F., Wang, M., Bieber, B.A., et al. (2015) Recent Changes in Therapeutic Approaches and Association with Outcomes among Patients with Secondary Hyperparathyroidism on Chronic Hemodialysis: The DOPPS Study. Clinical Journal of the American Society of Nephrology, 10, 98-109. [Google Scholar] [CrossRef] 
[16] Neves, K.R., Graciolli, F.G., Dos, R.L., et al. (2007) Vascular Calcification: Contribution of Parathyroid Hormone in Renal Failure. Kidney International, 71, 1262-1270. [Google Scholar] [CrossRef] [PubMed]
[17] 张蕊, 张念荣, 席秋萍, 等. 维持性血液透析合并难治性继发性甲状旁腺功能亢进患者腹主动脉钙化相关因素分析[J]. 肾脏病与透析肾移植杂志, 2017, 26(5): 432-437.
[18] 阮欣然, 杜小红, 刘萍, 等. 西那卡塞联合骨化三醇对维持性血液透析合并继发性甲状旁腺功能亢进患者冠状动脉钙化和心功能的影响[J]. 中国临床医生杂志, 2023, 51(3): 307-311.
[19] Freedman, B.I., Divers, J., Russell, G.B., et al. (2015) Plasma FGF23 and Calcified Atherosclerotic Plaque in African Americans with Type 2 Diabetes Mellitus. American Journal of Nephrology, 42, 391-401. [Google Scholar] [CrossRef] [PubMed]
[20] Donate-Correa, J., Martin-Nunez, E., Hernandez-Carballo, C., et al. (2019) Fibroblast Growth Factor 23 Expression in Human Calcified Vascular Tissues. Aging (Albany NY), 11, 7899-7913. [Google Scholar] [CrossRef] [PubMed]
[21] Huang, C.L. and Moe, O.W. (2011) Klotho: A Novel Regulator of Calcium and Phosphorus Homeostasis. Pflügers Archiv, 462, 185-193. [Google Scholar] [CrossRef] [PubMed]
[22] Desjardins, L., Liabeuf, S., Renard, C., et al. (2012) FGF23 Is Independently Associated with Vascular Calcification but Not Bone Mineral Density in Patients at Various CKD Stages. Osteoporosis International, 23, 2017-2025. [Google Scholar] [CrossRef] [PubMed]
[23] Kuro-o, M., Matsumura, Y., Aizawa, H., et al. (1997) Mutation of the Mouse Klotho Gene Leads to a Syndrome Resembling Ageing. Nature, 390, 45-51. [Google Scholar] [CrossRef] [PubMed]
[24] Palmer, S.C., Hayen, A., Macaskill, P., et al. (2011) Serum Levels of Phos-phorus, Parathyroid Hormone, and Calcium and Risks of Death and Cardiovascular Disease in Individuals with Chronic Kidney Disease: A Systematic Review and Meta-Analysis. JAMA, 305, 1119-1127. [Google Scholar] [CrossRef] [PubMed]
[25] Rivara, M.B., Ravel, V., Kalantar-Zadeh, K., et al. (2015) Uncorrected and Albumin-Corrected Calcium, Phosphorus, and Mortality in Patients Undergoing Maintenance Dialysis. Journal of the American Society of Nephrology, 26, 1671-1681. [Google Scholar] [CrossRef] 
[26] 吴胜英, 蔡嫣, 薛林, 等. 高钙血症加重大鼠血管钙化[J]. 中国动脉硬化杂志, 2008, 16(5): 337-340.
[27] Yamada, S., Tokumoto, M., Tatsumoto, N., et al. (2016) Very Low Protein Diet Enhances Inflammation, Malnutrition, and Vascular Calcification in Uremic Rats. Life Sciences, 146, 117-123. [Google Scholar] [CrossRef] [PubMed]
[28] Huang, M., Zheng, L., Xu, H., et al. (2020) Oxidative Stress Contributes to Vascular Calcification in Patients with Chronic Kidney Disease. The Journal of Molecular and Cellular Cardiology, 138, 256-268. [Google Scholar] [CrossRef] [PubMed]
[29] Marchesi, J.R., Adams, D.H., Fava, F., et al. (2016) The Gut Microbiota and Host Health: A New Clinical Frontier. Gut, 65, 330-339. [Google Scholar] [CrossRef] [PubMed]
[30] Lano, G., Burtey, S. and Sallee, M. (2020) Indoxyl Sulfate, a Uremic Endotheliotoxin. Toxins (Basel), 12, Article No. 229. [Google Scholar] [CrossRef] [PubMed]
[31] Adijiang, A., Goto, S., Uramoto, S., et al. (2008) Indoxyl Sulphate Promotes Aortic Calcification with Expression of Osteoblast-Specific Proteins in Hypertensive Rats. Nephrology Dialysis Transplantation, 23, 1892-1901. [Google Scholar] [CrossRef] [PubMed]
[32] Opdebeeck, B., Maudsley, S., Azmi, A., et al. (2019) Indoxyl Sulfate and p-Cresyl Sulfate Promote Vascular Calcification and Associate with Glucose Intolerance. Journal of the American Society of Nephrology, 30, 751-766. [Google Scholar] [CrossRef] 
[33] Li, T., Chen, Y., Gua, C., et al. (2017) Elevated Circulating Trimethylamine N-Oxide Levels Contribute to Endothelial Dysfunction in Aged Rats through Vascular Inflammation and Oxidative Stress. Frontiers in Physiology, 8, Article No. 350. [Google Scholar] [CrossRef] [PubMed]
[34] Seldin, M.M., Meng, Y., Qi, H., et al. (2016) Trimethylamine N-Oxide Promotes Vascular Inflammation through Signaling of Mitogen-Activated Protein Kinase and Nuclear Fac-tor-kappaB. Journal of the American Heart Association, 5, e002767. [Google Scholar] [CrossRef] 
[35] Zhang, X., Li, Y., Yang, P., et al. (2020) Trimethylamine-N-Oxide Promotes Vascular Calcification through Activation of NLRP3 (Nucleotide-Binding Domain, Leucine-Rich-Containing Family, Pyrin Domain-Containing-3) Inflammasome and NF-kappaB (Nuclear Factor kappaB) Signals. Arteriosclerosis, Thrombosis, and Vascular Biology, 40, 751-765. [Google Scholar] [CrossRef] 
[36] Park, C., Obi, Y., Streja, E., et al. (2017) Serum Uric Acid, Protein Intake and Mortality in Hemodialysis Patients. Nephrology Dialysis Transplantation, 32, 1750-1757. [Google Scholar] [CrossRef] [PubMed]
[37] Rodrigues, T.C., Maahs, D.M., Johnson, R.J., et al. (2010) Serum Uric Acid Predicts Progression of Subclinical Coronary Atherosclerosis in Individuals without Renal Disease. Diabetes Care, 33, 2471-2473. [Google Scholar] [CrossRef] [PubMed]
[38] Liang, L., Hou, X., Bainey, K.R., et al. (2019) The Association between Hyperuricemia and Coronary Artery Calcification Development: A Systematic Review and Meta-Analysis. Clinical Cardiology, 42, 1079-1086. [Google Scholar] [CrossRef] [PubMed]
[39] 胡壮彬, 陈瑞燕, 黄俊成. 血透患者血尿酸水平与血管钙化相关性及非布司他干预作用[J]. 数理医药学杂志, 2022, 35(9): 1339-1341.
[40] Dvornik, S., Cuk, M., Racki, S., et al. (2006) Serum Zinc Concentrations in the Maintenance Hemodialysis Patients. Collegium Antropologicum, 30, 125-129.
[41] Chen, W., Eisenberg, R., Mowrey, W.B., et al. (2020) Association between Dietary Zinc Intake and Abdominal Aortic Calcification in US Adults. Nephrology Dialysis Transplantation, 35, 1171-1178. [Google Scholar] [CrossRef] [PubMed]
[42] Zhang, D., Zhu, Y., Li, H., et al. (2023) Associations of Whole Blood Zinc Levels with Coronary Artery Calcification and Future Cardiovascular Events in CKD Patients. Biological Trace Element Research. [Google Scholar] [CrossRef] [PubMed]
[43] Nagy, A., Petho, D., Gall, T., et al. (2019) Zinc Inhibits HIF-Prolyl Hydroxylase Inhibitor-Aggravated VSMC Calcification Induced by High Phosphate. Frontiers in Physiology, 10, Article No. 1584. [Google Scholar] [CrossRef] [PubMed]
[44] Leenders, N., Vermeulen, E.A., van Ballegooijen, A.J., et al. (2021) The Association between Circulating Magnesium and Clinically Relevant Outcomes in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis. Clinical Nutrition, 40, 3133-3147. [Google Scholar] [CrossRef] [PubMed]
[45] Ter Braake, A.D., Tinnemans, P.T., Shanahan, C.M., et al. (2018) Magnesium Prevents Vascular Calcification in Vitro by Inhibition of Hydroxyapatite Crystal Formation. Scientific Re-ports, 8, Article No. 2069. [Google Scholar] [CrossRef] [PubMed]
[46] Chen, H.G., Sheng, L.T., Zhang, Y.B., et al. (2019) Association of Vitamin K with Cardiovascular Events and All-Cause Mortality: A Systematic Review and Meta-Analysis. European Journal of Nutrition, 58, 2191-2205. [Google Scholar] [CrossRef] [PubMed]
[47] 杨洁, 陈天怡, 王玲. 维持性血液透析患者腹主动脉钙化的危险因素[J]. 中国老年学杂志, 2021, 41(16): 3467-3471.
[48] 贾凤玉, 徐斌, 龚德华, 等. 维持性血液透析患者心血管钙化的发生率及分布特点[J]. 肾脏病与透析肾移植杂志, 2014, 23(5): 401-406.

为你推荐